Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01365039 · ClinicalTrials.gov registry record · NA
Safety and Efficacy of a Contact Lens for Daily Disposable Use
A NA study of Myopia, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 173
- Enrollment target
- 1
- Study location
NCT01365039: Completed NA study of Myopia, sponsored by Bausch & Lomb Incorporated.
NCT01365039 is a NA study of Myopia that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 173 participants, below the 266-participant average among 90 other Myopia trials with a reported enrollment target (35% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01365039, a NA study of Myopia, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 173 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is to evaluate the safety and efficacy of a new hydrogel daily disposable contact lens compared to the Bausch + Lomb SofLens® daily disposable contact lens when worn by current soft contact lens wearers on a daily disposable wear basis.
Primary Outcome
Statistical non-inferiority of Slit Lamp Findings \> Grade 2 at any visit between the Test and Control lenses
Conditions Studied
Interventions
- DEVICE Test, daily disposable contact lens
- DEVICE SofLens daily disposable contact lens
Study Locations (1)
New York
- Bausch & Lomb, Inc. - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 173 participants |
| Start Date | 2011-06 |
| Est. Completion | 2011-10 |
| Phase | NA |
What the finished NCT01365039 record still lists
NCT01365039 is an interventional study that assigns participants to a tested intervention. The registered 173 participants enrollment target is mid-sized for trials with a published cap, below the 266-participant average among 90 other Myopia trials with a reported enrollment target (35% lower).
The record links to 1 condition, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which Test, daily disposable contact lens is the first listed.
NCT01365039 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01365039 about?
NCT01365039 is a clinical study titled "Safety and Efficacy of a Contact Lens for Daily Disposable Use". This study is to evaluate the safety and efficacy of a new hydrogel daily disposable contact lens compared to the Bausch + Lomb SofLens® daily disposable contact lens when worn by current soft contact lens wearers on a daily disposable wear basis.
What is the current status of trial NCT01365039?
This trial is currently completed. It is a NA study. The enrollment target is 173 participants. The study started on 2011-06. Estimated completion is 2011-10.
What conditions does trial NCT01365039 study?
This clinical trial studies the following conditions: Myopia.
What interventions are being tested in trial NCT01365039?
The interventions under investigation include: Test, daily disposable contact lens (DEVICE), SofLens daily disposable contact lens (DEVICE).
Who is sponsoring clinical trial NCT01365039?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01365039 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01365039's enrollment target sits among peer trials
173 28th of 90 higher than 63 of 90 other Myopia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Efficacy of Repeated Low-level Red-light Therapy in Myopia Control
RECRUITING · NA
-
Comprehensive Assessment of Multiple Products (CAMP)
RECRUITING · NA
-
Children's Viewing Behavior
RECRUITING · NA
-
Violet Light for the Suppression of Myopia
RECRUITING · NA
-
Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
RECRUITING · NA
-
Wavelength Intervention for Nearsighted Kids
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05568719 · 173 participants · Phase 3
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
- NCT07070115 · 173 participants · NA
Evaluating Clinical Hiatal Hernia Outcomes Using OviTex®
- NCT07150832 · 173 participants · NA
Efficacy of the I-CARE Digital Health Intervention
- NCT01000259 · 174 participants
Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia